Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

VO200 – NeurOs Cerebral Oximetry System

N.º K: K182242 · 2018-12-26

SolicitanteMespere Lifesciences, Inc.
Fecha de decisión2018-12-26
Código de productoQEM
Comité asesorCV
DecisiónSubstantially Equivalent

Resumen del dispositivo

VO200 – NeurOs Cerebral Oximetry System is the device name listed in this FDA 510(k) record. The listed applicant is Mespere Lifesciences, Inc.. It received FDA 510(k) clearance on 2018-12-26 under 510(k) number K182242. The device is classified under product code QEM. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the VO200 – NeurOs Cerebral Oximetry System?

VO200 – NeurOs Cerebral Oximetry System is a medical device that received FDA 510(k) clearance on 2018-12-26. The listed applicant is Mespere Lifesciences, Inc.. The 510(k) number is K182242.

When did VO200 – NeurOs Cerebral Oximetry System receive FDA 510(k) clearance?

VO200 – NeurOs Cerebral Oximetry System received FDA 510(k) clearance on 2018-12-26, under 510(k) number K182242.

Who is the listed applicant for VO200 – NeurOs Cerebral Oximetry System?

The FDA 510(k) record lists Mespere Lifesciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VO200 – NeurOs Cerebral Oximetry System?

The FDA product code for VO200 – NeurOs Cerebral Oximetry System is QEM.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑